Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026
Clover Health (Nasdaq:CLOV) will report its second quarter 2026 financial results after market close on Wednesday, August 5, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Clover Health (Nasdaq:CLOV) will report its second quarter 2026 financial results after market close on Wednesday, August 5, 2026. Management will host a webcast at 5:00 p.m. Eastern Time to discuss quarterly business and financial performance, with a live and archived stream available.
Details
Market move: CLOV -5.13% in the Jul 10 session. 2Q26 earnings date announcement
On Jul 10, the first trading day after this news, CLOV closed 5.13% below the previous close. Argus tracked a trough of -3.0% from its starting point during tracking. Our momentum scanner recorded 9 alerts for this stock that day.
Data tracked by StockTitan Argus for the Jul 10 session.
Key Figures
- Earnings release date
- August 5, 2026
- Second Quarter 2026 results timing
- Earnings call time
- 5:00 p.m. Eastern Time
- Second Quarter 2026 webcast start
- Webcast archive duration
- 12 months
- Investor Relations website replay availability
Previous Earnings date Reports
-
Announced Q1 2026 earnings release timing and webcast access details.
-
Scheduled Q4 and full-year 2025 results release and related webcast.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
investor relations financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
WILMINGTON, Del., July 09, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Wednesday, August 5, 2026. The Company’s management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter.
Second Quarter 2026 Conference Webcast Details:
- What: Clover Health’s Second Quarter 2026 Earnings Conference Call
- When: Wednesday, August 5, 2026, at 5:00 p.m. Eastern Time
- Webcast: To access the webcast, you may register at https://clover-health-2q-2026-earnings.open-exchange.net/.
A live and archived webcast of the conference call will also be accessible from the Investor Relations section of Clover Health’s website at https://investors.cloverhealth.com/ for 12 months.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and in Underserved Populations as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Investor Relations:
Ryan Schmidt
investors@cloverhealth.com
Press Inquiries:
press@cloverhealth.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.